X
X

Dr. Vishal Kulkarni

   MBBS, DNB (General Medicine), DNB (Medical Oncology)

Book An Appointment

Home / Doctors / Dr. Vishal Kulkarni

Dr. Vishal Kulkarni

  Qualification

MBBS, DNB (General Medicine), DNB (Medical Oncology)

  Specialities

Medical Oncology
Haematology and Bone Marrow Transplant

  Locations

HCG NMR Cancer Centre - Hubli

  Experience

5 Years

Introduction
Expertise
  • Dr. Vishal Kulkarni has got an overall experience of more than 10 years and has worked and trained at some of the most reputed hospitals in India. 
  • He has done significant work in the field of immunotherapy. He has also been part of about 60 bone marrow transplants including autologous and allogeneic transplants.
  • He has administered immunotherapy in more than 500 patients and is well-versed in managing the unique side effect profile of these agents. He is also interested in clinical research and teaching.
  • Dr. Vishal has handled over 5000 cases so far.
Training and Certifications
  • Dr. Vishal has certifications in “Pain and Palliative Care Management” by IAPC and “Management of Diabetes” by Cleveland Clinic, USA.
Publications
  • Acute pancreatitis caused by pemetrexed, carboplatin, and gemcitabine in a patient with lung cancer: A rare case report (2019). Indian Journal of Medical and Paediatric Oncology, 40(S 01), S133-S135.
  • Correlation of ABO Blood Group And Aphthous Ulcers-An Epidemiological Study (2015). Journal of Advanced Medical and Dental Sciences Research, 3(4), 9.
  • Role of haematological profile in oral submucous fibrosis: a clinical study (2015). Journal of Advanced Medical and Dental Sciences Research, 3(4), 6.
  • Analysis of relapsed/refractory Hodgkin lymphoma treated with autologous transplantation: A single-centre experience (2020). Indian Journal of Medical and Paediatric Oncology, 41(01), 23-28.
  • Correlation Of Regorafenib With Kras And Kdr Gene Mutation In Patients With Chemotherapy Refractory Metastatic Colorectal Cancer”-asco Abstract#188288 June 2-6 2017.
  • Prospective Analysis Of Patients Treated With Chemotherapy In Metastatic Adenocarcinoma Of Lung—single Centre Experience- Scirp An Academic Publisher.
  • Correlation Of Grade Iii/Iv Gi Toxicity And Neutropenia In Patients Receiving 5fu Based Chemotherapy Regimen With Dpd Deficiency”- Asco Abstract #189020 June 2-6, 2017.
  • Safety and Efficacy of Neoadjuvant DOF Chemotherapy Regimen in patients with locally advanced gastro-esophageal junction cancers- A single center experience from India- journal of cancer therapy 2020,01,11(05):237-250.

   Practices at

Other Doctors

HCG Call Icon